Direct Flow Medical Inc., a Santa Rosa, Calif.-based developer of a minimally-invasive implant to treat heart valve disease, has secured $40 million of a $42.5 million third round of VC funding, according to a regulatory filing.
Direct Flow Medical Inc., a Santa Rosa, Calif.-based developer of a minimally-invasive implant to treat heart valve disease, has secured $40 million of a $42.5 million third round of VC funding, according to a regulatory filing.
